• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Prenome could help pregnant women better predict and manage gestational diabetes

September 22, 2021 by David Barret Leave a Comment

“We’re always trying to stick something up a women’s something.”

Stevie Cline, the co-founder of Prenome, is tired of how invasive diagnostic processes are for women, even with modern technology and broader healthcare advancements. So, she teamed up with her former co-worker, Sarah Brozio, to launch a startup all about providing actionable insights to women – no poking or prodding needed.

Prenome, going through TechCrunch Disrupt Startup Battlefield this week, is launching a saliva-based genetic test, paired with a behavioral app, to help women navigate gestational diabetes, a common condition that comes up while pregnant.

The startup’s success is rooted inextricably to data. In May, Prenome began recruiting patients who have had gestational diabetes for a clinical study, OneInSeven. The co-founders are using this data to build a more accurate pipeline of information about women’s health conditions, one that represents the actual diversity of women in the United States.

Prenome could help pregnant women better predict and manage gestational diabetes

Image Credits: Prenome

Once Prenome extracts a genetic risk score, it combines it with a risk score built off of social determinants, with factors like previous trauma, disposable income, proximity to grocery stores. By combining these two factors, Prenome claims it can accurately predict gestational diabetes at a 90% accuracy rate, compared to the 80% baseline today.

The co-founders picked gestational diabetes over the plethora of other women’s health conditions because it has a strong genetic component. Cline explained how gestational diabetes is predictable and preventable, which gives Prenome a chance at screening high-risk individuals and also providing interventions that will help them prevent getting gestational diabetes early on.

Once Prenome is able to develop technology that helps women navigate gestational diabetes, it can use that insight to better address associated conditions, such as infertility and polycystic ovary syndrome.

“People think that genetic diseases are usually caused by a single gene or a single chromosomal disorder, like Down Syndrome or Cystic Fibrosis,” Crozio said. “[They] wanted this idea that one gene equals one problem so we can fix that – but that’s actually really untrue for most of our health.” 

She explained part of the driver for the biobank is to be able to mine it for more and more indications on triggers within women’s health conditions. Similar to hormonal health, genetic health is complicated yet key in understanding the common threads between these conditions.

Prenome’s biggest stance may be that it doesn’t want to test for any condition that it can’t intervene or improve on.

“We’re never going to do a test [for] risk [of] Alzheimer’s in your 80s because there’s nothing really right now that we can do to prevent that from happening, women don’t need more stress” Cline said. “If we are telling you [that you are] high risk, it’s something that you can improve on, we can intervene on, we can provide for.”

Over a year since launch, Prenome has so far filed patents on both its test and methodology. It also plans to publish research with data from its OneInSeven Study.

The saliva-based test, which it hopes to release in 2022, is working to get CLIA-certified, which would allow physicians to order it for their patients. Eventually, Prenome will pursue FDA-approval, which would allow Prenome to go direct-to-consumers.

“Having doctors feel like they are cut out of the loop and that they are not important and part of the women’s health cycle is detrimental for us,” Cline said. “We really want to focus on how we engage people [and] get them to want to get their patients to use our tests.”

Prenome early strides have been noticed, and bet on. So far, Prenome has attracted $1 million worth of interest from investors, including Cleo Capital, OnDeck’s Runway Fund, Johns Hopkins University, Wing VC, First In Ventures and A-Level Capital.

 

Source Link Prenome could help pregnant women better predict and manage gestational diabetes

David Barret
David Barret

Related posts:

  1. In Buenos Aires downtown, a city seeks new lease of life after pandemic ‘iceberg’
  2. Brazil President Jair Bolsonaro signs decree changing social media regulations
  3. Analysis-Investors brace for a great fall in China
  4. Kin of Philippines ‘drug war victims’ hope for justice as ICC approves probe

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Have You Seen This Snake? Florida Wants Your Help Finding Rare Species Seen Once In 50 Years
  • Plague Confirmed In Lake Tahoe Area For First Time In 5 Years, California Officials Say
  • Supergiant Star Spotted Blowing Milky Way’s Largest Bubble Of Its Kind, Surprising Astronomers
  • Game Theory Promised To Explain Human Decisions. Did It?
  • Genes, Hormones, And Hairstyling – Here Are Some Causes Of Hair Loss You Might Not Have Heard Of
  • Answer To 30-Year-Old Mystery Code Embedded In The Kryptos CIA Sculpture To Be Sold At Auction
  • Merry Mice: Human Brain Cells Transplanted Into Mice Reduce Anxiety And Depression
  • Asteroid-Bound NASA Mission Snaps Earth-Moon Portrait From 290 Million Kilometers Away
  • Forget State Mammals – Some States Have Official Dinosaurs, And They’re Awesome
  • Female Jumping Spiders Of Two Species Prefer The Sexy Red Males Of One, Leading To Hybridization
  • Why Is It So Difficult To Find New Moons In The Solar System?
  • New “Oxygen-Breathing” Crystal Could Recharge Fuel Cells And More
  • Some Gut Bacteria Cause Insomnia While Others Protect Against It, 400,000-Person Study Argues
  • Neanderthals And Homo Sapiens Got It On 100,000 Years Earlier Than We Thought
  • “Womb Of The Universe”: Native American Tribal Elders Help Archaeologists Decipher Ancient Rock Art In Missouri Cave
  • 16,000-Year-Old Paintings Suggest Prehistoric Humans Risked Their Lives To Enter “Shaman Training Cave”
  • Final Gasps Of A Dying Star Seen Through A Record-Breaking 130 Years Of Data
  • COVID-19 “Vaccine Alternative” Injection Could Be On Fast-Track To Approval From FDA
  • New Jersey Officials Investigate Possible First Locally Acquired Malaria Case Since 1991
  • First-of-Its-Kind Bright Orange Nurse Shark Recorded Off Costa Rica Makes History
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version